Heart Failure Society of America's 14th Annual Scientific Meeting convenes September 12, 2010

The Heart Failure Society of America (HFSA) 14th Annual Scientific Meeting convened Sunday, September 12, 2010 at the San Diego Convention Center in San Diego. This four-day meeting -- a forum for heart failure specialists to present research findings and advances in treatment -- will address emerging trends in research and new developments in the approach to treating patients with all stages of heart failure.

The scientific program will kick off with an opening plenary session, "Novel Technologies and Models in Cardiovascular Disease" on Monday, September 13 at 8:30 a.m. Prior to the opening session, the 2010 HFSA Lifetime Achievement Award will be presented to Dr. Eugene Braunwald, Distinguished Hersey Professor of Medicine at Harvard Medical School, Chairman of the TIMI Study Group and Brigham and Women's Hospital, and holder of Science Watch's title "Most Frequently Cited Author in Cardiology."

Following the opening plenary will be simultaneous sessions with presentations by national and international heart failure experts, scientists, and allied health care professionals.  Many will focus on the progressive treatments for heart failure and the increased risk faced by patients.

"This year's conference will present exciting new information on the most recent advances in the field of heart failure, from the most important advances in basic science to the latest clinical trials that will affect how we take care of heart failure patients," said Dr. Douglas Mann, HFSA President. "This year's meeting will provide an important forum for all health care providers and scientists who are interested in heart failure. Thought leaders in the field will discuss causes and treatment of heart failure and the important socio-economic issues surrounding this condition."  

The Annual Scientific Meeting will include presentations on:

• Comparative Genomics and Human Disease: Some Recent Contributions from Zoos
• Latest Developments in Stem Cell and Gene Therapy in Heart Failure
• Can We Afford to Use Mechanical Devices for Heart Failure?
• Managing Salt in the Diet
• Depression and Heart Failure: Is Diagnosing the Blues Helpful?
• End-of-Life: Transitioning to Palliative Care

For a complete list of annual meeting sessions or for details on attending the conference, call (617) 226-7183 or visit www.hfsa.org and click on Annual Scientific Meeting. There is no registration fee for accredited journalists. Interview areas will be available on-site in addition to a fully-staffed press room with phone and internet accessibility. You may follow news from the meeting on Twitter #HFSA

SOURCE The Heart Failure Society of America